申请人:Daiichi Sankyo Company, Limited
公开号:EP1939205A1
公开(公告)日:2008-07-02
The present invention relates to tricyclic compounds each represented by the following formula (I):
(wherein, R1, R2, R2', R3, R4, X, Y and Z have the same meanings as defined in the specification); and a drug containing the compound.
Since the compounds according to the present invention exhibit an excellent squalene synthetase inhibitory effect and cholesterol synthesis inhibitory effect so that they are useful as a drug such as preventive and/or remedy for diseases in mammals including humans such as hyperlipemia, e.g., hypercholesterolemia, hypertriglyceridemia, and low HDL cholesterolemia and/or arteriosclerosis.
本发明涉及一种三环化合物,每种化合物由以下式(I)表示:(其中,R1、R2、R2'、R3、R4、X、Y和Z的含义与规范中定义的含义相同);以及含有该化合物的药物。由于根据本发明的化合物表现出优异的角鲨烯合酶抑制作用和胆固醇合成抑制作用,因此它们可用作哺乳动物(包括人类)的疾病预防和/或治疗药物,例如高脂血症,如高胆固醇血症、高甘油三酯血症、低高密度脂蛋白胆固醇血症和/或动脉粥样硬化。